CN113774075B - 一株大肠杆菌基因工程菌及其发酵生产l-茶氨酸的方法 - Google Patents
一株大肠杆菌基因工程菌及其发酵生产l-茶氨酸的方法 Download PDFInfo
- Publication number
- CN113774075B CN113774075B CN202111159099.6A CN202111159099A CN113774075B CN 113774075 B CN113774075 B CN 113774075B CN 202111159099 A CN202111159099 A CN 202111159099A CN 113774075 B CN113774075 B CN 113774075B
- Authority
- CN
- China
- Prior art keywords
- gene
- theanine
- fermentation
- escherichia coli
- ethylamine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 title claims abstract description 149
- 238000000855 fermentation Methods 0.000 title claims abstract description 80
- 230000004151 fermentation Effects 0.000 title claims abstract description 80
- DATAGRPVKZEWHA-UHFFFAOYSA-N L-gamma-glutamyl-n-ethylamine Natural products CCNC(=O)CCC(N)C(O)=O DATAGRPVKZEWHA-UHFFFAOYSA-N 0.000 title claims abstract description 72
- 241000588724 Escherichia coli Species 0.000 title claims abstract description 55
- 241000894006 Bacteria Species 0.000 title claims abstract description 45
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 17
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 claims abstract description 88
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 39
- 239000008103 glucose Substances 0.000 claims abstract description 39
- 239000011347 resin Substances 0.000 claims abstract description 19
- 229920005989 resin Polymers 0.000 claims abstract description 19
- 239000002253 acid Substances 0.000 claims abstract description 15
- 101150106096 gltA gene Proteins 0.000 claims abstract description 15
- 101150006213 ackA gene Proteins 0.000 claims abstract description 14
- 239000012528 membrane Substances 0.000 claims abstract description 12
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 11
- 101100433987 Latilactobacillus sakei subsp. sakei (strain 23K) ackA1 gene Proteins 0.000 claims abstract description 11
- 101150042350 gltA2 gene Proteins 0.000 claims abstract description 10
- 238000002425 crystallisation Methods 0.000 claims abstract description 9
- 230000008025 crystallization Effects 0.000 claims abstract description 9
- 238000005516 engineering process Methods 0.000 claims abstract description 6
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 5
- 101150038987 xylR gene Proteins 0.000 claims abstract description 5
- 230000001502 supplementing effect Effects 0.000 claims abstract 2
- 238000000034 method Methods 0.000 claims description 24
- 108090000623 proteins and genes Proteins 0.000 claims description 23
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 claims description 22
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 21
- 239000002773 nucleotide Substances 0.000 claims description 18
- 125000003729 nucleotide group Chemical group 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 101150023641 ppc gene Proteins 0.000 claims description 15
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 12
- 239000000047 product Substances 0.000 claims description 11
- 101100351124 Bacillus subtilis (strain 168) pckA gene Proteins 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 10
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 10
- 230000001133 acceleration Effects 0.000 claims description 10
- 239000000919 ceramic Substances 0.000 claims description 10
- 238000010276 construction Methods 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 10
- 238000010362 genome editing Methods 0.000 claims description 10
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 9
- 229910052760 oxygen Inorganic materials 0.000 claims description 9
- 239000001301 oxygen Substances 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 9
- 108010092060 Acetate kinase Proteins 0.000 claims description 7
- 108091000041 Phosphoenolpyruvate Carboxylase Proteins 0.000 claims description 7
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 7
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 7
- -1 phosphoacetyl Chemical group 0.000 claims description 7
- 101150054674 ylbE gene Proteins 0.000 claims description 7
- 108010049926 Acetate-CoA ligase Proteins 0.000 claims description 6
- 108090000364 Ligases Proteins 0.000 claims description 6
- 150000001450 anions Chemical class 0.000 claims description 6
- 238000001471 micro-filtration Methods 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 6
- 108010030844 2-methylcitrate synthase Proteins 0.000 claims description 5
- 108010071536 Citrate (Si)-synthase Proteins 0.000 claims description 5
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 claims description 5
- 101100160180 Escherichia coli (strain K12) yjiT gene Proteins 0.000 claims description 5
- 240000008042 Zea mays Species 0.000 claims description 5
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 5
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 5
- 235000005822 corn Nutrition 0.000 claims description 5
- 101150073818 gap gene Proteins 0.000 claims description 5
- 238000011081 inoculation Methods 0.000 claims description 5
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 5
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 5
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 5
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 5
- 108091033409 CRISPR Proteins 0.000 claims description 4
- 101100320446 Escherichia coli (strain K12) yghE gene Proteins 0.000 claims description 4
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 4
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 3
- 238000010453 CRISPR/Cas method Methods 0.000 claims description 3
- 241001087674 Methylovorus mays Species 0.000 claims description 3
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 3
- 125000002091 cationic group Chemical group 0.000 claims description 3
- 150000001768 cations Chemical class 0.000 claims description 3
- 239000013078 crystal Substances 0.000 claims description 3
- 230000001404 mediated effect Effects 0.000 claims description 3
- 239000000049 pigment Substances 0.000 claims description 3
- 238000002834 transmittance Methods 0.000 claims description 3
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical class OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 2
- 108020002494 acetyltransferase Proteins 0.000 claims description 2
- 239000003957 anion exchange resin Substances 0.000 claims description 2
- 239000003729 cation exchange resin Substances 0.000 claims description 2
- 108090000992 Transferases Proteins 0.000 claims 3
- 239000001963 growth medium Substances 0.000 claims 3
- 238000005086 pumping Methods 0.000 claims 3
- 238000001816 cooling Methods 0.000 claims 2
- GSXOAOHZAIYLCY-UHFFFAOYSA-N D-F6P Natural products OCC(=O)C(O)C(O)C(O)COP(O)(O)=O GSXOAOHZAIYLCY-UHFFFAOYSA-N 0.000 claims 1
- 101000952691 Homo sapiens Dephospho-CoA kinase Proteins 0.000 claims 1
- 102000004357 Transferases Human genes 0.000 claims 1
- 229940100228 acetyl coenzyme a Drugs 0.000 claims 1
- BGWGXPAPYGQALX-ARQDHWQXSA-N beta-D-fructofuranose 6-phosphate Chemical compound OC[C@@]1(O)O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O BGWGXPAPYGQALX-ARQDHWQXSA-N 0.000 claims 1
- 108010049285 dephospho-CoA kinase Proteins 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- 239000002609 medium Substances 0.000 claims 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 claims 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims 1
- 230000001954 sterilising effect Effects 0.000 claims 1
- 238000004659 sterilization and disinfection Methods 0.000 claims 1
- VNOYUJKHFWYWIR-ITIYDSSPSA-N succinyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCC(O)=O)O[C@H]1N1C2=NC=NC(N)=C2N=C1 VNOYUJKHFWYWIR-ITIYDSSPSA-N 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 abstract description 14
- 238000000926 separation method Methods 0.000 abstract description 5
- 241001302584 Escherichia coli str. K-12 substr. W3110 Species 0.000 abstract description 4
- 239000000758 substrate Substances 0.000 abstract description 4
- 238000010353 genetic engineering Methods 0.000 abstract description 2
- 108020004414 DNA Proteins 0.000 description 58
- 239000012634 fragment Substances 0.000 description 53
- 238000011144 upstream manufacturing Methods 0.000 description 30
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 18
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 16
- 210000004027 cell Anatomy 0.000 description 14
- 238000013461 design Methods 0.000 description 11
- 101150108780 pta gene Proteins 0.000 description 11
- 101150006699 xfp gene Proteins 0.000 description 11
- 239000000203 mixture Substances 0.000 description 10
- 230000001580 bacterial effect Effects 0.000 description 9
- 239000001888 Peptone Substances 0.000 description 8
- 108010080698 Peptones Proteins 0.000 description 8
- 238000012258 culturing Methods 0.000 description 8
- 238000010586 diagram Methods 0.000 description 8
- 235000019319 peptone Nutrition 0.000 description 8
- 239000011780 sodium chloride Substances 0.000 description 8
- 244000269722 Thea sinensis Species 0.000 description 7
- 229960000723 ampicillin Drugs 0.000 description 7
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 7
- 238000005215 recombination Methods 0.000 description 7
- 230000006798 recombination Effects 0.000 description 7
- 229960000268 spectinomycin Drugs 0.000 description 7
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 7
- 210000004748 cultured cell Anatomy 0.000 description 6
- 238000004042 decolorization Methods 0.000 description 6
- 238000001962 electrophoresis Methods 0.000 description 6
- 230000004060 metabolic process Effects 0.000 description 6
- 230000004048 modification Effects 0.000 description 6
- 238000012986 modification Methods 0.000 description 6
- 230000009469 supplementation Effects 0.000 description 6
- 238000012795 verification Methods 0.000 description 6
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 5
- 229910019142 PO4 Inorganic materials 0.000 description 5
- LIPOUNRJVLNBCD-UHFFFAOYSA-N acetyl dihydrogen phosphate Chemical compound CC(=O)OP(O)(O)=O LIPOUNRJVLNBCD-UHFFFAOYSA-N 0.000 description 5
- 101150047711 acs gene Proteins 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 230000010354 integration Effects 0.000 description 5
- 239000010452 phosphate Substances 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- 235000013616 tea Nutrition 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- 108700023175 Phosphate acetyltransferases Proteins 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 238000000137 annealing Methods 0.000 description 4
- 235000015278 beef Nutrition 0.000 description 4
- 229940041514 candida albicans extract Drugs 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 230000002503 metabolic effect Effects 0.000 description 4
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 4
- 239000013612 plasmid Substances 0.000 description 4
- 239000008223 sterile water Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- 239000012138 yeast extract Substances 0.000 description 4
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 description 3
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 3
- 229930091371 Fructose Natural products 0.000 description 3
- 239000005715 Fructose Substances 0.000 description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
- 102000003960 Ligases Human genes 0.000 description 3
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 3
- 108010075728 Succinate-CoA Ligases Proteins 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- XWBDWHCCBGMXKG-UHFFFAOYSA-N ethanamine;hydron;chloride Chemical compound Cl.CCN XWBDWHCCBGMXKG-UHFFFAOYSA-N 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000011218 seed culture Methods 0.000 description 3
- 101150118203 yeeL gene Proteins 0.000 description 3
- 101150110708 yghE gene Proteins 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- 101100488216 Bacillus subtilis (strain 168) yesE gene Proteins 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 2
- 241000186018 Bifidobacterium adolescentis Species 0.000 description 2
- 239000002028 Biomass Substances 0.000 description 2
- HMFHBZSHGGEWLO-IOVATXLUSA-N D-xylofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H]1O HMFHBZSHGGEWLO-IOVATXLUSA-N 0.000 description 2
- 241000701867 Enterobacteria phage T7 Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 101100376115 Escherichia coli (strain K12) yeeL gene Proteins 0.000 description 2
- 101100431984 Escherichia coli (strain K12) yeeP gene Proteins 0.000 description 2
- 101100544116 Escherichia coli (strain K12) yghX gene Proteins 0.000 description 2
- 101710107035 Gamma-glutamyltranspeptidase Proteins 0.000 description 2
- 101710173228 Glutathione hydrolase proenzyme Proteins 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 235000006468 Thea sinensis Nutrition 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 229910000365 copper sulfate Inorganic materials 0.000 description 2
- 238000012364 cultivation method Methods 0.000 description 2
- 102000006640 gamma-Glutamyltransferase Human genes 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 239000012465 retentate Substances 0.000 description 2
- 229940073490 sodium glutamate Drugs 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229940026510 theanine Drugs 0.000 description 2
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 101150010108 xylF gene Proteins 0.000 description 2
- 101150063727 yjiT gene Proteins 0.000 description 2
- FHHHTPCMJKCGEY-JEDNCBNOSA-N (2s)-2-amino-5-(ethylamino)-5-oxopentanoic acid;sulfuric acid Chemical compound OS(O)(=O)=O.CCNC(=O)CC[C@H](N)C(O)=O FHHHTPCMJKCGEY-JEDNCBNOSA-N 0.000 description 1
- OWEFQTXQEHYDEJ-UHFFFAOYSA-N 2,3-dihydroxypropanal diphosphono hydrogen phosphate Chemical compound OCC(O)C=O.OP(O)(=O)OP(O)(=O)OP(O)(O)=O OWEFQTXQEHYDEJ-UHFFFAOYSA-N 0.000 description 1
- 102000008146 Acetate-CoA ligase Human genes 0.000 description 1
- 101100380241 Caenorhabditis elegans arx-2 gene Proteins 0.000 description 1
- 235000009024 Ceanothus sanguineus Nutrition 0.000 description 1
- 102000006732 Citrate synthase Human genes 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-WUJLRWPWSA-N D-xylulose Chemical compound OC[C@@H](O)[C@H](O)C(=O)CO ZAQJHHRNXZUBTE-WUJLRWPWSA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 241000701959 Escherichia virus Lambda Species 0.000 description 1
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 1
- 108020005004 Guide RNA Proteins 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 240000003553 Leptospermum scoparium Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 102000018120 Recombinases Human genes 0.000 description 1
- 108010091086 Recombinases Proteins 0.000 description 1
- 244000042430 Rhodiola rosea Species 0.000 description 1
- 102000011929 Succinate-CoA Ligases Human genes 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 101150092805 actc1 gene Proteins 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000004177 carbon cycle Methods 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229940116318 copper carbonate Drugs 0.000 description 1
- 229910001431 copper ion Inorganic materials 0.000 description 1
- GEZOTWYUIKXWOA-UHFFFAOYSA-L copper;carbonate Chemical compound [Cu+2].[O-]C([O-])=O GEZOTWYUIKXWOA-UHFFFAOYSA-L 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000909 electrodialysis Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000008394 flocculating agent Substances 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 229940049906 glutamate Drugs 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 108700010833 lambda phage proteins Proteins 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000012269 metabolic engineering Methods 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 229930029653 phosphoenolpyruvate Natural products 0.000 description 1
- DTBNBXWJWCWCIK-UHFFFAOYSA-N phosphoenolpyruvic acid Chemical compound OC(=O)C(=C)OP(O)(O)=O DTBNBXWJWCWCIK-UHFFFAOYSA-N 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/14—Glutamic acid; Glutamine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/22—Separation; Purification; Stabilisation; Use of additives
- C07C231/24—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1217—Phosphotransferases with a carboxyl group as acceptor (2.7.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y203/00—Acyltransferases (2.3)
- C12Y203/01—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
- C12Y203/01008—Phosphate acetyltransferase (2.3.1.8)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y203/00—Acyltransferases (2.3)
- C12Y203/03—Acyl groups converted into alkyl on transfer (2.3.3)
- C12Y203/03001—Citrate (Si)-synthase (2.3.3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/02—Phosphotransferases with a carboxy group as acceptor (2.7.2)
- C12Y207/02001—Acetate kinase (2.7.2.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y401/00—Carbon-carbon lyases (4.1)
- C12Y401/01—Carboxy-lyases (4.1.1)
- C12Y401/01031—Phosphoenolpyruvate carboxylase (4.1.1.31)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y401/00—Carbon-carbon lyases (4.1)
- C12Y401/02—Aldehyde-lyases (4.1.2)
- C12Y401/02022—Fructose-6-phosphate phosphoketolase (4.1.2.22)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y602/00—Ligases forming carbon-sulfur bonds (6.2)
- C12Y602/01—Acid-Thiol Ligases (6.2.1)
- C12Y602/01003—Long-chain-fatty-acid-CoA ligase (6.2.1.3)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y203/00—Acyltransferases (2.3)
- C12Y203/03—Acyl groups converted into alkyl on transfer (2.3.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y401/00—Carbon-carbon lyases (4.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y602/00—Ligases forming carbon-sulfur bonds (6.2)
- C12Y602/01—Acid-Thiol Ligases (6.2.1)
- C12Y602/01001—Acetate-CoA ligase (6.2.1.1)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
本发明属于生物工程领域,具体涉及一种利用大肠杆菌基因工程菌发酵生产L‑茶氨酸的方法。所述工程菌是以大肠杆菌W3110基因组上单拷贝T7RNAP、双拷贝gmas、敲除xylR、敲除sucCD后获得菌株为出发菌种,在基因组上整合xfp、pta、acs、gltA、ppc,敲除ackA获得。采用OD联动的乙胺补加策略以葡萄糖等廉价碳源为底物从头高效合成L‑茶氨酸,糖酸转化率高、生产性能稳定,20‑25h后L‑茶氨酸的产量可达75‑80g/L,糖酸转化率达到52‑55%。发酵液采用膜分离结合阴阳离子树脂串联技术进行纯化,一次结晶收率72.3%,L‑茶氨酸成品纯度达到99%。
Description
技术领域:
本发明属于生物工程领域,具体涉及一种利用大肠杆菌基因工程菌发酵生产L-茶氨酸的方法。
技术背景:
L-茶氨酸(N-乙基-γ-L-谷氨酰胺)是茶叶中特有的一种非蛋白质氨基酸,于1950年由日本学者酒户弥二郎从玉露茶中分离得到并命名。L-茶氨酸主要存在于茶树类植物中,通常以游离形式存在,不参与合成蛋白质,占茶树体内游离氨基酸总量的40%-70%。L-茶氨酸在茶汤中泡出率可达80%,是茶汤呈现鲜爽味的主要成分,与绿茶等级的正相关系数达0.787-0.876,也是评价其他茶类品质和风味的重要物质。随着对L-茶氨酸生理活性研究的深入,其在食品、保健和医学领域有着广泛的应用前景。
目前食品级的L-茶氨酸均采用微生物合成法获得。CN103409475B报道了通过人工合成获得γ-谷氨酰转肽酶的基因,并以大肠杆菌为宿主菌构建一种过量表达γ-谷氨酰转肽酶的基因工程菌,以重组酶作用于不同浓度的谷氨酰胺和乙胺盐酸盐得到L-茶氨酸。CN104087535B报道了使用保藏编号为CCTCC M2014254的硝基还原假单胞菌NTLC4.002为出发菌株制备细胞、细胞转化谷氨酰胺和乙胺制备L-茶氨酸。CN106893748B报道了以γ-谷氨酰甲胺合成酶和磷酸激酶为催化剂,以L-谷氨酸钠、乙胺盐酸盐和少量ATP为底物合成L-茶氨酸。CN102719367B报道了使用从茶树根际土壤筛选得到的近玫色锁掷孢酵母生产γ-谷氨基甲酰胺合成酶,再用该酶催化L-谷氨酸钠、乙胺盐酸盐和ATP生产L-茶氨酸。微生物酶促合成L-茶氨酸的主要问题在于需要以价格较高的谷氨酰胺、谷氨酸盐和ATP为原料,因此生产成本极高,产品难以大规模应用。
以葡萄糖为原料通过微生物发酵制备L-茶氨酸的方法(CN109370966B、CN109777763B),具有原料简单易得,生产环节简单,成本较低的特点。但发酵法生产L-茶氨酸仍存在产量低、糖酸转化率较低、副产物较多等问题。此外,由于乙胺对于微生物生长存在抑制作用,会造成发酵过程中菌体浓度降低,部分菌体自溶,从而使得发酵液成分复杂,产物难于提取。
茶氨酸的分离提取方面,CN105061249B公布了一种通过超滤去除废液中大分子物质,然后添加碱式碳酸铜和稀硫酸,反应生成茶氨酸-硫酸铜,再通过电渗析去除茶氨酸-硫酸铜中的铜离子和硫酸根离子,然后减压浓缩去除淡水室内的水份,再使用无水乙醇分离出硫酸-茶氨酸中的硫酸。CN109851520A公布了一种通过向L-茶氨酸反应液中加入絮凝剂和离子去除剂后,经过超滤、脱色、浓缩、结晶等步骤得到L-茶氨酸。上述提取方法中均用到了大量的酸碱试剂或絮凝剂,收率及产品纯度低,因此,也亟需一种高纯度的L-茶氨酸的分离纯化方法。
发明内容:
本发明目的是通过基因组改造获得一株糖酸转化率高、生产性能稳定的用于L-茶氨酸生产的基因工程菌并提供其发酵、提纯方法。
针对上述存在的问题,本发明技术方案如下:
本发明提供的技术方案之一,是一株无质粒、以葡萄糖等廉价碳源为底物从头高效合成L-茶氨酸的基因工程菌。该基因工程菌株是以ZL 201811215068.6(CN109370966)构建的L-茶氨酸生产基因工程菌为出发菌,通过以下改造获得:在基因组上整合6-磷酸果糖解酮酶基因xfp、磷酸乙酰基转移酶基因pta、乙酰辅酶A合成酶基因acs、柠檬酸合酶基因gltA、磷酸烯醇丙酮酸羧化酶基因ppc,敲除乙酸激酶基因ackA。
进一步地,所述6-磷酸果糖解酮酶基因xfp来源于双歧杆菌(B.adolescentis)ATCC 15703,核苷酸序列如序列表SEQ ID NO.1所示;
进一步地,所述磷酸乙酰基转移酶基因pta来源于大肠杆菌(E.coli)ATCC27325,核苷酸序列如序列表SEQ ID NO.2所示;
进一步地,所述乙酰辅酶A合成酶基因acs来源于大肠杆菌(E.coli)ATCC27325,核苷酸序列如序列表SEQ ID NO.3所示;
进一步地,所述柠檬酸合酶基因gltA来源于大肠杆菌(E.coli)ATCC 27325,核苷酸序列如序列表SEQ ID NO.4所示;
进一步地,所述磷酸烯醇丙酮酸羧化酶基因ppc来源于大肠杆菌(E.coli)ATCC27325,核苷酸序列如序列表SEQ ID NO.5所示;
进一步地,所述乙酸激酶基因ackA的核苷酸序列如序列表SEQ ID NO.6所示;
优选地,xfp、pta、acs、gltA、ppc基因均分别由trc启动子控制;
所述ZL 201811215068.6构建的L-茶氨酸生产基因工程菌,是在大肠杆菌(Escherichia coli)W3110基因组上单拷贝来源于T7噬菌体的RNA聚合酶基因T7RNAP,该基因由木糖启动子控制;双拷贝来源于Methylovorus mays的γ-谷氨酰甲胺合成酶基因gmas,该基因由T7启动子控制;敲除木糖操纵子阻遏蛋白基因xylR;敲除琥珀酰CoA合成酶基因sucCD。
本发明提供的技术方案之二,是上述基因工程菌的构建方法,本发明中采用CRISPR/Cas 9介导的基因编辑技术对大肠杆菌进行定向改造,具体包括如下步骤:
(1)为了加强碳循环,减少碳源损失,在出发菌株基因组gapC位点单拷贝来源于双歧杆菌(B.adolescentis)ATCC 15703的6-磷酸果糖解酮酶基因xfp(SEQ ID NO.1所示),该基因由trc启动子控制;
(2)为了加强乙酰磷酸到乙酰辅酶A的代谢,在出发菌株基因组yjiT位点单拷贝来源于大肠杆菌ATCC 27325的乙酰基转移酶基因pta(SEQ ID NO.2所示);
(3)为了加强乙酸到乙酰辅酶A的代谢,在出发菌株基因组yghE位点单拷贝来源于大肠杆菌ATCC 27325的乙酰辅酶A合成酶基因acs(SEQ ID NO.3所示);
(4)为了加强乙酰辅酶A到柠檬酸的代谢,在出发菌株基因组ylbE位点单拷贝来源于大肠杆菌ATCC 27325的磷酸乙酰基转移酶gltA(SEQ ID NO.4所示);
(5)为了加强磷酸烯醇式丙酮酸到草酰乙酸的代谢,在出发菌株基因组yeeL位点单拷贝来源于大肠杆菌ATCC 27325的磷酸烯醇丙酮酸羧化酶ppc(SEQ ID NO.5所示);
(6)为了减少乙酸的积累,敲除出发菌株基因组上的乙酸激酶基因ackA(SEQ IDNO.6所示);
其中,步骤(1)-(6)的构建顺序不分先后,可根据需求进行调整。将最终获得的基因工程菌株命名为E.coli THEE。
本发明提供的技术方案之三,是上述基因工程菌的应用,特别是在采用发酵法生产L-茶氨酸中的应用;
进一步地,采用上述基因工程菌E.coli THEE发酵生产L-茶氨酸的方法具体如下:
发酵培养:将种子液按照10-15%接种量接入新鲜的发酵培养基,发酵过程中控制pH在6.7-7.2,温度维持在28-36℃,溶氧在10-30%之间;当培养基中的葡萄糖消耗完之后,流加葡萄糖溶液并维持发酵培养基中的葡萄糖浓度<1g/L;
进一步地,流加600g/L的葡萄糖溶液维持发酵培养基中的葡萄糖浓度<1g/L;
进一步地,为了减少乙胺对于菌体生长的影响,发酵过程中采用OD联动的乙胺补加策略,当OD600nm达到8-12以上时开始添加乙胺,每0.8-1.2小时调节一次乙胺流加速率;乙胺流加速率(g·L-1·h-1)=0.5×OD600nm值/(发酵液体积(L)×发酵时间(h));
5L发酵罐发酵20-25h后L-茶氨酸的产量可达75-80g/L,糖酸转化率达到52-55%。
进一步地,种子培养方法如下:取适量无菌水于茄形瓶中,将菌悬液接入种子培养基中,pH稳定在7.0左右,温度恒定在37℃,溶氧在25-35%之间,培养至细胞干重达到5-6g/L;
进一步地,斜面培养方法如下:从-80℃冰箱保菌管中刮一环菌种,均匀涂布于活化斜面,37℃培养12-16h,转接茄形瓶继续培养12-16h;
优选地,斜面培养基组成为:葡萄糖1-5g/L,蛋白胨5-10g/L,牛肉膏5-10g/L,酵母粉1-5g/L,氯化钠1-2.5g/L,琼脂15-20g/L,pH 7.0-7.2;
种子培养基组成为:葡萄糖20-30g/L,酵母提取物5-10g/L,蛋白胨10-20g/L,氯化钠10-20g/L,其余为水,pH 7.0-7.2;
发酵培养基组成为:葡萄糖10-40g/L,酵母粉2-8g/L,玉米浆2-20ml/L,柠檬酸0.2-2.0g/L,磷酸二氢钾0.5-3.2g/L,磷酸氢二钾0.5-2.4g/L,硫酸镁0.2-1.2g/L,其余为水,pH 7.0-7.2。
本发明提供的技术方案之四,是从上述发酵液中分离提取L-茶氨酸的方法,具体如下:
(1)在发酵罐中将L-茶氨酸发酵液加热升温至55-60℃维持20-30min后降温至35-40℃,过50-70nm陶瓷膜进行微滤除菌并收集滤出液,0.2-0.3Mpa压力下,当滤出液流速低于5mL/min时,补加0.5-1倍发酵液体积的水,直至截留液中L-茶氨酸浓度小于2g/L时,结束陶瓷膜微滤;
(2)将陶瓷膜滤液过阳离子树脂吸附L-茶氨酸,然后用质量分数为0.5%-1%的氨水进行洗脱收集;将洗脱液过阴离子树脂吸附色素,收集树脂流出液;
优选地,所述阳离子树脂为001×7苯乙烯系强酸阳离子交换树脂;
优选地,所述的阴离子树脂为D213丙烯酸系强碱阴离子交换树脂;
(3)将树脂流出液泵入脱色罐中,加入L-茶氨酸质量1%-3%的药用活性炭进行脱色处理,至料液透光率达到96%以上;将脱色液泵入蒸发器中进行减压浓缩至体积浓缩倍数为6-9倍;
进一步地,减压浓缩维持真空度-0.08MPa,温度60℃;
(4)将浓缩液泵入结晶罐中,加入浓缩液体积30%-50%的乙醇,真空冷却结晶,离心分离收集湿晶体,烘干后得到L-茶氨酸成品。
本发明的有益效果:
(1)由于丙酮酸脱氢酶催化丙酮酸形成乙酰CoA和CO2,所以大肠杆菌经糖酵解途径最多将一分子葡萄糖转化为两分子乙酰CoA,剩余部分以CO2形式损失,严重限制了葡萄糖到L-茶氨酸的转化率。本发明通过引入6-磷酸果糖解酮酶,可最多将一分子葡萄糖转化为三分子乙酰CoA。将6-磷酸果糖解酮酶基因整合到大肠杆菌基因组上,构建出和6-磷酸果糖和5-磷酸木酮糖到乙酰磷酸的代谢途径,再通过强化内源磷酸乙酰基转移酶的表达,使乙酰磷酸转变为乙酰CoA。上述代谢改造策略可以有效减少丙酮酸到乙酰CoA的代谢,从而减少碳损,提高了葡萄糖到L-茶氨酸的转化率。
(2)大肠杆菌发酵过程中会产生一定量的副产物乙酸,影响菌体正常生长。乙酰磷酸的过量合成会进一步加剧乙酸的积累。为了减少副产物乙酸的含量,本申请敲除了乙酸激酶,阻断了乙酰磷酸到乙酸的代谢,同时强化内源乙酰辅酶A合成酶的表达,使乙酸转变为乙酰CoA。上述代谢改造策略可以有效减少乙酸对菌体生长的抑制作用,提升了单位菌体的产酸率。
(3)异型发酵途径的引入会造成三磷酸甘油醛和乙酰CoA的积累。为了增强三羧酸循环的代谢通量,本申请强化内源柠檬酸合酶和磷酸烯醇丙酮酸羧化酶的表达,为三羧酸循环起始反应即柠檬酸的合成提供了充足的酶和底物草酰乙酸。
(4)乙胺是L-茶氨酸发酵的前体物,但大量的乙胺对菌体细胞具有较强的毒害作用。在发酵过程采用恒速流加乙胺策略可以有效控制发酵液中乙胺的浓度,但是菌体不同生长阶段对乙胺的消耗不同,恒定补料会影响菌体的产酸能力。本申请根据菌体生长不同周期对于乙胺的耐受程度,开发了OD联动的乙胺补料技术,将乙胺流加速率和菌体生物量偶联,拟合出经验方程,使得菌体能够最大程度的代谢乙胺生产L-茶氨酸,从而大幅度提升了生物量和产酸量。
(5)本发明不使用传统的沉淀法提纯L-茶氨酸技术,采用膜分离结合阴阳离子树脂串联技术,减少了活性炭使用,提高了产品收率及产品质量,一次结晶收率72.3%,成品纯度为99%。本发明只需一次结晶即可拿到合格产品,不需要精制,缩短了纯化路线,降低了污染风险,增加了生产的稳定性。
附图说明:
图1基因工程菌E.coli THEE代谢改造策略图
其中灰色填充基因为本申请改造点;
图2gapC::Ptrc-xfp整合电泳图
其中,M—1kb Maker;1—上游同源臂;2—目的基因;3—下游同源臂;4—重叠片段;5—原菌PCR片段;6—目的菌PCR片段;
图3yjiT::Ptrc-pta整合电泳图
其中,M—1kb Maker;1—上游同源臂;2—目的基因;3—下游同源臂;4—重叠片段;5—原菌PCR片段;6—目的菌PCR片段;
图4yghE::Ptrc-acs整合电泳图
其中,M—1kb Maker;1—上游同源臂;2—目的基因;3—下游同源臂;4—重叠片段;5—原菌PCR片段;6—目的菌PCR片段;
图5ylbE::Ptrc-gltA整合电泳图
其中,M—1kb Maker;1—上游同源臂;2—目的基因;3—下游同源臂;4—重叠片段;5—原菌PCR片段;6—目的菌PCR片段;
图6yeeL::Ptrc-ppc整合电泳图
其中,M—1kb Maker;1—上游同源臂;2—目的基因;3—下游同源臂;4—重叠片段;5—原菌PCR片段;6—目的菌PCR片段;
图7ackA敲除电泳图
其中,M—1kb Maker;1—上游同源臂;2—下游同源臂;3—重叠片段;4—原菌PCR片段;5—目的菌PCR片段;
图8基因工程菌E.coli THEE 5L罐发酵进程图;
图9乙胺流速线性拟合图。
具体实施方式:
为了使本专利的目的、技术方案及优点更加清楚明白,以下结合具体实施例,对本专利进行进一步详细说明。应当理解,此处所描述的具体实施例仅仅用以解释本专利,并不用于限定本发明。
本发明以ZL 201811215068.6(CN 109370966)构建的L-茶氨酸生产基因工程菌为出发菌,该菌株是在大肠杆菌W3110基因组上lacI-lacZ位点单拷贝来源于T7噬菌体的RNA聚合酶基因T7RNAP(核苷酸序列见CN 109370966 B序列表1),该基因由木糖启动子PxylF控制;在W3110基因组上yghX及yeeP位点双拷贝来源于Methylovorus mays的γ-谷氨酰甲胺合成酶基因gmas(核苷酸序列见CN 109370966B序列表2),该基因经过密码子优化并由T7启动子控制;敲除W3110的木糖操纵子阻遏蛋白基因xylR;敲除W3110的琥珀酰CoA合成酶基因sucCD获得。详细构建过程可参考CN 109370966 B。
本发明所用trc启动子序列如下:TTGACAATTAATCATCCGGCTCGTATAATGTGTGGAATTGTGAGCGGATAAC AATTTCACACAGGAAACAGACC。
本发明实施例中,大肠杆菌E.coli THEE构建过程涉及的xfp、pta、acs、gltA、ppc、ackA基因序列见序列表SEQ ID NO.1-6所示。
以下将结合附图,通过具体实施方式对本发明作进一步地解释说明。
实施例1:基因工程菌株大肠杆菌E.coli THEE的构建(改造策略见图1):
1、基因编辑的方法
本发明中采用CRISPR/Cas 9介导的基因编辑方法参照文献(MetabolicEngineering,2015,31:13-21.)进行,该方法所用的两个质粒分别为pGRB与pREDCas9。其中pREDCas9携带gRNA质粒消除系统,λ噬菌体的Red重组系统及Cas9蛋白表达系统,奇霉素抗性(工作浓度:100mg/L),32℃培养;pGRB质粒,以pUC18为骨架,包括启动子J23100,gRNA-Cas9结合区域序列和终止子序列,氨苄青霉素抗性(工作浓度:100mg/L),37℃培养。
2、菌株构建的具体过程
以ZL 201811215068.6构建的L-茶氨酸生产基因工程菌(在大肠杆菌W3110基因组上lacI-lacZ位点单拷贝来源于T7噬菌体的RNA聚合酶基因T7RNAP(核苷酸序列见CN109370966 B序列表1),该基因由木糖启动子PxylF控制;在基因组上yghX及yeeP位点双拷贝γ-谷氨酰甲胺合成酶基因gmas(核苷酸序列见CN109370966B序列表2),该基因经过密码子优化并由T7启动子控制;敲除木糖操纵子阻遏蛋白基因xylR;敲除W3110的琥珀酰CoA合成酶基因sucCD获得)为出发菌,并进行如下改造:
2.1将Ptrc-xfp(含有trc启动子和xfp基因的片段)整合在假基因gapC位点处
以E.coli ATCC27325基因组为模板,根据其gapC基因的上、下游序列设计上游同源臂引物UP-gapC-S(SEQ ID NO.7)、UP-gapC-A(SEQ ID NO.8)和下游同源臂引物DN-gapC-S(SEQ ID NO.9)、DN-gapC-A(SEQ ID NO.10),并扩增gapC基因的上、下游同源臂;根据xfp基因设计引物xfp-S(SEQ ID NO.11)、xfp-A(SEQ ID NO.12),并扩增xfp基因片段。启动子Ptrc则设计在gapC基因上游同源臂的下游引物和xfp基因的上游引物中。上述片段通过重叠PCR的方法获得xfp基因的整合片段(gapC基因上游同源臂-Ptrc-xfp-gapC基因下游同源臂),构建pGRB-gapC使用的含靶序列的DNA片段通过引物gRNA-gapC-S(SEQ ID NO.13)和gRNA-gapC-A(SEQ ID NO.14)的退火制得,与线性化的pGRB载体重组后获得重组的pGRB-gapC。将整合片段和pGRB-gapC电转化至含有pREDCas9载体的大肠杆菌出发菌株感受态细胞中,将电转化后复苏培养的菌体涂布于含氨苄青霉素和奇霉素的LB平板上,32℃过夜培养后利用PCR验证阳性重组子,再消除用于基因编辑的pGRB-gapC。验证图如图2所示。
2.2将Ptrc-pta(含有trc启动子和pta基因的片段)整合在假基因yjiT位点处
以E.coli ATCC27325基因组为模板,根据其yjiT基因的上、下游序列设计上游同源臂引物Up-yjiT-S(SEQ ID NO.15)、Up-yjiT-A(SEQ ID NO.16)和下游同源臂引物DN-yjiT-S(SEQ ID NO.17)、DN-yjiT-A(SEQ ID NO.18),并扩增yjiT基因的上、下游同源臂;根据pta基因设计引物pta-S(SEQ ID NO.19)、pta-A(SEQ ID NO.20),并扩增pta基因片段。启动子ptrc则设计在yjiT基因上游同源臂的下游引物和pta基因的上游引物中。上述片段通过重叠pCR的方法获得pta基因的整合片段(yjiT基因上游同源臂-Ptrc-pta-yjiT基因下游同源臂),构建pGRB-yjiT使用的含靶序列的DNA片段通过引物gRNA-yjiT-S(SEQ ID NO.21)和gRNA-yjiT-A(SEQ ID NO.22)的退火制得,与线性化的pGRB载体重组后获得重组的pGRB-yjiT。将整合片段和pGRB-yjiT电转化至含有pREDCas9载体的上步构建的大肠杆菌感受态细胞中,将电转化后复苏培养的菌体涂布于含氨苄青霉素和奇霉素的LB平板上,32℃过夜培养后利用pCR验证阳性重组子,再消除用于基因编辑的pGRB-yjiT。验证图如图3所示。
2.3将Ptrc-acs(含有trc启动子和acs基因的片段)整合在假基因yghE位点处
以E.coli ATCC27325基因组为模板,根据其yghE基因的上、下游序列设计上游同源臂引物UP-yghE-S(SEQ ID NO.23)、UP-yghE-A(SEQ ID NO.24)和下游同源臂引物DN-yghE-S(SEQ ID NO.25)、DN-yghE-A(SEQ ID NO.26),并扩增yghE基因的上、下游同源臂;根据acs基因设计引物acs-S(SEQ ID NO.27)、acs-A(SEQ ID NO.28),并扩增acs基因片段。启动子Ptrc则设计在yghE基因上游同源臂的下游引物和acs基因的上游引物中。上述片段通过重叠PCR的方法获得acs基因的整合片段(yghE基因上游同源臂-Ptrc-acs-yghE基因下游同源臂),构建pGRB-yghE使用的含靶序列的DNA片段通过引物gRNA-yghE-S(SEQ IDNO.29)和gRNA-yghE-A(SEQ ID NO.30)的退火制得,与线性化的pGRB载体重组后获得重组的pGRB-yghE。将整合片段和pGRB-yghE电转化至含有pREDCas9载体的上步构建的大肠杆菌感受态细胞中,将电转化后复苏培养的菌体涂布于含氨苄青霉素和奇霉素的LB平板上,32℃过夜培养后利用PCR验证阳性重组子,再消除用于基因编辑的pGRB-yghE。验证图如图4所示。
2.4将Ptrc-gltA(含有trc启动子和gltA基因的片段)整合在假基因ylbE位点处
以E.coli(ATCC27325)基因组为模板,根据其ylbE基因的上、下游序列设计上游同源臂引物UP-ylbE-S(SEQ ID NO.31)、UP-ylbE-A(SEQ ID NO.32)和下游同源臂引物DN-ylbE-S(SEQ ID NO.33)、DN-ylbE-A(SEQ ID NO.34),并扩增ylbE基因的上、下游同源臂;根据gltA基因设计引物gltA-S(SEQ IDNO.35)、gltA-A(SEQ ID NO.36),并扩增gltA基因片段。启动子Ptrc则设计在ylbE基因上游同源臂的下游引物和gltA基因的上游引物中。上述片段通过重叠PCR的方法获得gltA基因的整合片段(ylbE基因上游同源臂-Ptrc-gltA-ylbE基因下游同源臂),构建pGRB-ylbE使用的含靶序列的DNA片段通过引物gRNA-ylbE-S(SEQ IDNO.37)和gRNA-ylbE-A(SEQ ID NO.38)的退火制得,与线性化的pGRB载体重组后获得重组的pGRB-ylbE。将整合片段和pGRB-ylbE电转化至含有pREDCas9载体的上步构建的大肠杆菌感受态细胞中,将电转化后复苏培养的菌体涂布于含氨苄青霉素和奇霉素的LB平板上,32℃过夜培养后利用PCR验证阳性重组子,再消除用于基因编辑的pGRB-ylbE。验证图如图5所示。
2.5将Ptrc-ppc(含有trc启动子和ppc基因的片段)整合在假基因yeeL位点处
以E.coli ATCC27325基因组为模板,根据其yeeL基因的上、下游序列设计上游同源臂引物UP-yeeL-S(SEQ ID NO.39)、UP-yeeL-A(SEQ ID NO.40)和下游同源臂引物DN-yeeL-S(SEQ ID NO.41)、DN-yeeL-A(SEQ ID NO.42),并扩增yeeL基因的上、下游同源臂;根据ppc基因设计引物ppc-S(SEQ ID NO.43)、ppc-A(SEQ ID NO.44),并扩增ppc基因片段。启动子Ptrc则设计在yeeL基因上游同源臂的下游引物和ppc基因的上游引物中。上述片段通过重叠PCR的方法获得ppc基因的整合片段(yeeL基因上游同源臂-Ptrc-ppc-yeeL基因下游同源臂),构建pGRB-yeeL使用的含靶序列的DNA片段通过引物gRNA-yeeL-S(SEQ ID NO.45)和gRNA-yeeL-A(SEQ ID NO.46)的退火制得,与线性化的pGRB载体重组后获得重组的pGRB-yeeL。将整合片段和pGRB-yeeL电转化至含有pREDCas9载体的上步构建的大肠杆菌感受态细胞中,将电转化后复苏培养的菌体涂布于含氨苄青霉素和奇霉素的LB平板上,32℃过夜培养后利用PCR验证阳性重组子,再消除用于基因编辑的pGRB-yeeL。验证图如图6所示。
2.6ackA基因的敲除
根据ackA基因的上、下游序列设计上游同源臂引物UP-ackA-S(SEQ IDNO.47)、UP-ackA-A(SEQ ID NO.48)和下游同源臂引物DN-ackA-S(SEQ ID NO.49)、DN-ackA-A(SEQ IDNO.50),并PCR扩增其上、下游同源臂片段;上述片段通过重叠PCR的方法获得ackA基因的敲除片段(ackA上游同源臂-ackA下游同源臂)。设计引物gRNA-ackA-S(SEQ ID NO.51)和gRNA-ackA-A(SEQ ID NO.52)扩增包含靶序列的DNA片段,与线性化的pGRB载体重组后获得重组的pGRB-ackA。将敲除片段和pGRB-ackA电转化至含有pREDCas9载体的上步构建的大肠杆菌感受态细胞中,将电转化后复苏培养的菌体涂布于含氨苄青霉素和奇霉素的LB平板上,32℃过夜培养后利用PCR验证阳性重组子,再消除用于基因编辑的pGRB-ackA和pREDCas9。验证图如图7所示。
上述步骤的顺序可根据实际情况进行调整,最终获得菌株E.coli THEE。
3.菌株构建过程中用到的引物
菌株构建过程中所涉及的所有引物见下表:
实施例2:菌株E.coli THEE 5L发酵罐发酵生产L-茶氨酸
斜面培养基组成为:葡萄糖2g/L,蛋白胨6g/L,牛肉膏6g/L,酵母粉3g/L,氯化钠2g/L,琼脂18g/L,pH 7.0。
种子培养基组成为:葡萄糖25g/L,酵母提取物6g/L,蛋白胨15g/L,氯化钠15g/L,其余为水,pH 7.0。
发酵培养基组成为:葡萄糖30g/L,酵母粉6g/L,玉米浆8ml/L,柠檬酸1.5g/L,磷酸二氢钾2.5g/L,磷酸氢二钾2.0g/L,硫酸镁1.0g/L,其余为水,pH 7.2。
(1)斜面培养:从-80℃冰箱保菌管中刮一环菌种,均匀涂布于活化斜面,37℃培养14h,转接茄形瓶继续培养14h;
(2)种子培养:取适量无菌水于茄形瓶中,将菌悬液接入种子培养基中,pH稳定在7.0左右,温度恒定在37℃,溶氧在30-34%之间,培养至细胞干重达到6g/L;
(3)发酵培养:将种子液按照12%接种量接入新鲜的发酵培养基,发酵过程中控制pH在7.0,温度维持在36℃,溶氧在25-30%之间;当培养基中的葡萄糖消耗完之后,流加600g/L的葡萄糖溶液并维持发酵培养基中的葡萄糖浓度<1g/L;
为了比较不同乙胺补料方式对于发酵结果的影响,设置对照组和实验组:
对照组采用本领域常用的乙胺流加方式,即当OD600=20时开始以30mL/h的速率恒速流加2mol/L的乙胺溶液至发酵结束;
实验组采用OD联动的乙胺补加策略,乙胺流加速率(g·L-1·h-1)=0.5×OD600nm值/(发酵液体积(L)×发酵时间(h)),当OD600nm达到10以上时开始添加乙胺,每小时调节一次乙胺流加速率。
5L发酵罐发酵22h后L-茶氨酸的产量和糖酸转化率如下表所示,实验组发酵过程曲线如图8所示(本发明糖酸转化率为:(L-茶氨酸产量/葡萄糖消耗量)×100%):
组别 | L-茶氨酸产量(g/L) | 糖酸转化率(%) | 最高OD600nm值 |
实验组 | 80±2.5 | 55±1.2 | 81±2.6 |
对照组 | 72±2.1 | 50±1.3 | 53±3.5 |
实施例3:OD联动乙胺补加策略的确定
在5L发酵罐中发酵生产L-茶氨酸,当OD600nm达到10以上时开始添加乙胺,根据菌体消耗葡萄糖的程度,每小时对乙胺流加速度进行不同程度的调整,保证耗糖速率维持在7-8g·L-1·h-1。收集50批次L-茶氨酸产量达到80g/L的发酵批报,计算不同发酵时间下的平均OD600nm值、平均发酵液体积以及平均乙胺流加速率,如下表所示:
按照上述表格中数据使用ORIGIN软件进行线性拟合,Y值为平均乙胺流加速率,X值为平均OD600nm值/(平均发酵液体积(L)×发酵时间(h)。拟合结果如图9所示。根据拟合方程获得OD联动的乙胺补加策略,即乙胺流加速率(g·L-1·h-1)=0.5×OD600nm值/(发酵液体积(L)×发酵时间(h))。
实施例4:从发酵液中分离提取L-茶氨酸
(1)实施例2发酵结束后共得发酵液体积3.2L,L-茶氨酸含量80g/L,共计256g。将发酵液加热升温至60℃维持30min后降温至35℃。过50nm陶瓷膜进行微滤除菌并收集滤出液,在0.2Mpa下当滤出液流速低于5mL/min时,补加0.8倍发酵液体积的水,直至截留液中L-茶氨酸浓度为1.3g/L时,结束陶瓷膜微滤。
(2)将5.1L陶瓷膜滤出液(L-茶氨酸含量48.8g/L)过001×7阳离子树脂吸附L-茶氨酸,吸附量160g(L-茶氨酸)/L(树脂),然后用0.6%氨水进行洗脱收集,所得洗脱液体积4.6L(L-茶氨酸含量52.9g/L)。将洗脱液过D213阴离子树脂吸附色素,收集4.8L树脂流出液(L-茶氨酸含量为49.3g/L)。
(3)将树脂流出液泵入脱色罐中,加入L-茶氨酸质量2%的药用活性炭(4.7g)进行脱色处理,至料液透光率达到98%。将脱色液泵入蒸发器中进行减压浓缩,维持真空度-0.08MPa,温度60℃,浓缩至体积600mL(L-茶氨酸含量为364.2g/L)。
(4)将浓缩液泵入结晶罐中,加入240mL 95%乙醇,真空冷却结晶,离心分离得到母液820mL,收集湿晶体215.0g,水分13.9%,烘干后得到L-茶氨酸成品185g,一次结晶收率72.3%。经液相检测,成品纯度为99%。
实施例5:菌株E.coli THEE 5L发酵罐发酵生产L-茶氨酸
斜面培养基组成为:葡萄糖1g/L,蛋白胨5g/L,牛肉膏5g/L,酵母粉1g/L,氯化钠1g/L,琼脂15g/L,pH 7.0-7.2;
种子培养基组成为:葡萄糖20g/L,酵母提取物5g/L,蛋白胨10g/L,氯化钠10g/L,其余为水,pH 7.0-7.2;
发酵培养基组成为:葡萄糖10g/L,酵母粉2g/L,玉米浆2ml/L,柠檬酸0.2g/L,磷酸二氢钾0.5g/L,磷酸氢二钾0.5g/L,硫酸镁0.2g/L,其余为水,pH 7.0-7.2。
(1)斜面培养:从-80℃冰箱保菌管中刮一环菌种,均匀涂布于活化斜面,37℃培养16h,转接茄形瓶继续培养16h;
(2)种子培养:取适量无菌水于茄形瓶中,将菌悬液接入种子培养基中,pH稳定在7.0左右,温度恒定在37℃,溶氧在25-35%之间,培养至细胞干重达到5g/L;
(3)发酵培养:将种子液按照15%接种量接入新鲜的发酵培养基,发酵过程中控制pH在6.7-7.2,温度维持在28℃,溶氧在10-30%之间;当培养基中的葡萄糖消耗完之后,流加600g/L的葡萄糖溶液并维持发酵培养基中的葡萄糖浓度<1g/L;
实验组采用OD联动的乙胺补加策略,乙胺流加速率(g·L-1·h-1)=0.5×OD600nm值/(发酵液体积(L)×发酵时间(h)),当OD600nm达到10以上时开始添加乙胺,每小时调节一次乙胺流加速率。
5L发酵罐发酵20h后L-茶氨酸的产量为75g/L,糖酸转化达到52%。
实施例6:菌株E.coli THEE 5L发酵罐发酵生产L-茶氨酸
斜面培养基组成为:葡萄糖5g/L,蛋白胨10g/L,牛肉膏10g/L,酵母粉5g/L,氯化钠2.5g/L,琼脂20g/L,pH 7.0-7.2;
种子培养基组成为:葡萄糖30g/L,酵母提取物10g/L,蛋白胨20g/L,氯化钠20g/L,其余为水,pH 7.0-7.2;
发酵培养基组成为:葡萄糖40g/L,酵母粉8g/L,玉米浆20ml/L,柠檬酸2.0g/L,磷酸二氢钾3.2g/L,磷酸氢二钾2.4g/L,硫酸镁1.2g/L,其余为水,pH 7.0-7.2;
(1)斜面培养:从-80℃冰箱保菌管中刮一环菌种,均匀涂布于活化斜面,37℃培养12h,转接茄形瓶继续培养12h;
(2)种子培养:取适量无菌水于茄形瓶中,将菌悬液接入种子培养基中,pH稳定在7.0左右,温度恒定在37℃,溶氧在25-35%之间,培养至细胞干重达到6g/L;
(3)发酵培养:将种子液按照12%接种量接入新鲜的发酵培养基,发酵过程中控制pH在6.7-7.2,温度维持在35℃,溶氧在10-30%之间;当培养基中的葡萄糖消耗完之后,流加600g/L的葡萄糖溶液并维持发酵培养基中的葡萄糖浓度<1g/L;
实验组采用OD联动的乙胺补加策略,乙胺流加速率(g·L-1·h-1)=0.5×OD600nm值/(发酵液体积(L)×发酵时间(h)),当OD600nm达到10以上时开始添加乙胺,每小时调节一次乙胺流加速率。
5L发酵罐发酵25h后L-茶氨酸的产量为77g/L,糖酸转化达到53%。
以上所述实施例仅表达了本发明的几种实施方式,其描述较为详细,但并不能因此而理解为对专利范围的限制。应当指出的是,对于本领域的普通技术人员来说,在不脱离本专利构思的前提下,上述各实施方式还可以做出若干变形、组合和改进,这些都属于本专利的保护范围。因此,本专利的保护范围应以权利要求为准。
SEQUENCE LISTING
<110> 天津科技大学
<120> 一株大肠杆菌基因工程菌及其发酵生产L-茶氨酸的方法
<130> 1
<160> 52
<170> PatentIn version 3.5
<210> 1
<211> 2478
<212> DNA
<213> 双歧杆菌(B. adolescentis)ATCC 15703
<400> 1
atgacctctc cggttatcgg taccccgtgg aaaaaactga acgcgccggt ttctgaagaa 60
gcgatcgaag gtgttgacaa atactggcgt gcggcgaact acctgtctat cggtcagatc 120
tacctgcgtt ctaacccgct gatgaaagaa ccgttcaccc gtgaagacgt tagacaccgt 180
ctggttggtc actggggtac caccccgggt ctgaacttcc tgatcggtca catcaaccgt 240
ctgatcgcgg accaccagca gaacaccgtt atcatcatgg gtccgggtca cggtggtccg 300
gcgggtaccg cgcagtctta cctggacggt acctacaccg aatacttccc gaacatcacc 360
aaagacgaag cgggtctgca gaaattcttc cgtcagttct cttacccggg tggtatcccg 420
tctcactacg cgccggaaac cccgggttct atccacgaag gtggtgaact gggttacgcg 480
ctgtctcacg cgtacggtgc ggttatgaac aacccgtctc tgttcgttcc ggcgatcgtt 540
ggtgacggtg aagcggaaac cggtccgctg gcgaccggtt ggcagtctaa caaactgatc 600
aacccgcgta ccgacggtat cgttctgccg atcctgcacc tgaacggtta caaaatcgcg 660
aacccgacca tcctgtctcg tatctctgac gaagaactgc acgagttctt ccacggtatg 720
ggttacgaac cgtacgagtt cgttgcgggt ttcgacaacg aagaccacct gtctatccac 780
cgtcgtttcg cggaactgtt cgaaaccgtt ttcgacgaaa tctgcgacat caaagcggcg 840
gcgcagaccg acgacatgac ccgtccgttc tacccgatga tcatcttccg taccccgaaa 900
ggttggacct gcccgaaatt catcgacggt aaaaaaaccg aaggttcttg gcgttctcac 960
caggttccgc tggcgtctgc gcgtgacacc gaagcgcact tcgaagttct gaaaaactgg 1020
ctggaatctt acaaaccgga aaaactgttc gacgaaaacg gtgcggttaa accggaagtt 1080
accgcgttca tgccgaccgg tgaactgcgt atcggtgaaa acccgaacgc gaacggtggt 1140
cgtatccgtg aagaactgaa actgccgaaa ctggaagact acgaagttaa agaagttgcg 1200
gaatacggtc acggttgggg tcagctggaa gcgacccgtc gtctgggtgt ttacacccgt 1260
gacatcatca aaaacaaccc ggactctttc cgtatcttcg gtccggacga aaccgcgtct 1320
aaccgtctgc aggcggcgta cgacgttacc aacaaacagt gggacgcggg ttacctgtct 1380
gcgcaggttg acgaacacat ggcggttacc ggtcaggtta ccgaacagct gtctgaacac 1440
cagatggaag gtttcctgga aggttacctg ctgaccggtc gtcacggtat ctggtcttct 1500
tacgaatctt tcgttcacgt tatcgactct atgctgaacc agcacgcgaa atggctggaa 1560
gcgaccgttc gtgaaatccc gtggcgtaaa ccgatctctt ctatgaacct gctggtttct 1620
tctcacgttt ggcgtcagga ccacaacggt ttctctcacc aggacccggg tgttacctct 1680
gttctgctga acaaatgctt caacaacgac cacgttatcg gtatctactt cccggttgac 1740
tctaacatgc tgctggcggt tgcggaaaaa tgctacaaat ctaccaacaa aatcaacgcg 1800
atcatcgcgg gtaaacagcc ggcggcgacc tggctgaccc tggacgaagc gcgtgcggaa 1860
ctggaaaaag gtgcggcgga atggaaatgg gcgtctaacg ttaaatctaa cgacgaagcg 1920
cagatcgttc tggcggcgac cggtgacgtt ccgacccagg aaatcatggc ggcggcggac 1980
aaactggacg cgatgggtat caaattcaaa gttgttaacg ttgttgacct ggttaaactg 2040
cagtctgcga aagaaaacaa cgaagcgctg tctgacgaag agttcgcgga actgttcacc 2100
gaagacaaac cggttctgtt cgcgtaccac tcttacgcgc gtgacgttcg tggtctgatc 2160
tacgaccgtc cgaaccacga caacttcaac gttcacggtt acgaagaaca gggttctacc 2220
accaccccgt acgacatggt tcgtgttaac aacatcgacc gttacgaact gcaggcggaa 2280
gcgctgcgta tgatcgacgc ggacaaatac gcggacaaaa tcaacgaact ggaagcgttc 2340
cgtcaggaag cgttccagtt cgcggttgac aacggttacg accacccgga ctacaccgac 2400
tgggtttact ctggtgttaa caccaacaaa cagggtgcga tctctgcgac cgcggcgacc 2460
gcgggtgaca acgaatga 2478
<210> 2
<211> 2145
<212> DNA
<213> 大肠杆菌(E. coli)ATCC 27325
<400> 2
gtgtcccgta ttattatgct gatccctacc ggaaccagcg tcggtctgac cagcgtcagc 60
cttggcgtga tccgtgcaat ggaacgcaaa ggcgttcgtc tgagcgtttt caaacctatc 120
gctcagccgc gtaccggtgg cgatgcgccc gatcagacta cgactatcgt gcgtgcgaac 180
tcttccacca cgacggccgc tgaaccgctg aaaatgagct acgttgaagg tctgctttcc 240
agcaatcaga aagatgtgct gatggaagag atcgtcgcaa actaccacgc taacaccaaa 300
gacgctgaag tcgttctggt tgaaggtctg gtcccgacac gtaagcacca gtttgcccag 360
tctctgaact acgaaatcgc taaaacgctg aatgcggaaa tcgtcttcgt tatgtctcag 420
ggcactgaca ccccggaaca gctgaaagag cgtatcgaac tgacccgcaa cagcttcggc 480
ggtgccaaaa acaccaacat caccggcgtt atcgttaaca aactgaacgc accggttgat 540
gaacagggtc gtactcgccc ggatctgtcc gagattttcg acgactcttc caaagctaaa 600
gtaaacaatg ttgatccggc gaagctgcaa gaatccagcc cgctgccggt tctcggcgct 660
gtgccgtgga gctttgacct gatcgcgact cgtgcgatcg atatggctcg ccacctgaat 720
gcgaccatca tcaacgaagg cgacatcaat actcgccgcg ttaaatccgt cactttctgc 780
gcacgcagca ttccgcacat gctggagcac ttccgtgccg gttctctgct ggtgacttcc 840
gcagaccgtc ctgacgtgct ggtggccgct tgcctggcag ccatgaacgg cgtagaaatc 900
ggtgccctgc tgctgactgg cggttacgaa atggacgcgc gcatttctaa actgtgcgaa 960
cgtgctttcg ctaccggcct gccggtattt atggtgaaca ccaacacctg gcagacctct 1020
ctgagcctgc agagcttcaa cctggaagtt ccggttgacg atcacgaacg tatcgagaaa 1080
gttcaggaat acgttgctaa ctacatcaac gctgactgga tcgaatctct gactgccact 1140
tctgagcgca gccgtcgtct gtctccgcct gcgttccgtt atcagctgac tgaacttgcg 1200
cgcaaagcgg gcaaacgtat cgtactgccg gaaggtgacg aaccgcgtac cgttaaagca 1260
gccgctatct gtgctgaacg tggtatcgca acttgcgtac tgctgggtaa tccggcagag 1320
atcaaccgtg ttgcagcgtc tcagggtgta gaactgggtg cagggattga aatcgttgat 1380
ccagaagtgg ttcgcgaaag ctatgttggt cgtctggtcg aactgcgtaa gaacaaaggc 1440
atgaccgaaa ccgttgcccg cgaacagctg gaagacaacg tggtgctcgg tacgctgatg 1500
ctggaacagg atgaagttga tggtctggtt tccggtgctg ttcacactac cgcaaacacc 1560
atccgtccgc cgctgcagct gatcaaaact gcaccgggca gctccctggt atcttccgtg 1620
ttcttcatgc tgctgccgga acaggtttac gtttacggtg actgtgcgat caacccggat 1680
ccgaccgctg aacagctggc agaaatcgcg attcagtccg ctgattccgc tgcggccttc 1740
ggtatcgaac cgcgcgttgc tatgctctcc tactccaccg gtacttctgg tgcaggtagc 1800
gacgtagaaa aagttcgcga agcaactcgt ctggcgcagg aaaaacgtcc tgacctgatg 1860
atcgacggtc cgctgcagta cgacgctgcg gtaatggctg acgttgcgaa atccaaagcg 1920
ccgaactctc cggttgcagg tcgcgctacc gtgttcatct tcccggatct gaacaccggt 1980
aacaccacct acaaagcggt acagcgttct gccgacctga tctccatcgg gccgatgctg 2040
cagggtatgc gcaagccggt taacgacctg tcccgtggcg cactggttga cgatatcgtc 2100
tacaccatcg cgctgactgc gattcagtct gcacagcagc agtaa 2145
<210> 3
<211> 1959
<212> DNA
<213> 大肠杆菌(E. coli)ATCC 27325
<400> 3
atgagccaaa ttcacaaaca caccattcct gccaacatcg cagaccgttg cctgataaac 60
cctcagcagt acgaggcgat gtatcaacaa tctattaacg tacctgatac cttctggggc 120
gaacagggaa aaattcttga ctggatcaaa ccttaccaga aggtgaaaaa cacctccttt 180
gcccccggta atgtgtccat taaatggtac gaggacggca cgctgaatct ggcggcaaac 240
tgccttgacc gccatctgca agaaaacggc gatcgtaccg ccatcatctg ggaaggcgac 300
gacgccagcc agagcaaaca tatcagctat aaagagctgc accgcgacgt ctgccgcttc 360
gccaataccc tgctcgagct gggcattaaa aaaggtgatg tggtggcgat ttatatgccg 420
atggtgccgg aagccgcggt tgcgatgctg gcctgcgccc gcattggcgc ggtgcattcg 480
gtgattttcg gcggcttctc gccggaagcc gttgccgggc gcattattga ttccaactca 540
cgactggtga tcacttccga cgaaggtgtg cgtgccgggc gcagtattcc gctgaagaaa 600
aacgttgatg acgcgctgaa aaacccgaac gtcaccagcg tagagcatgt ggtggtactg 660
aagcgtactg gcgggaaaat tgactggcag gaagggcgcg acctgtggtg gcacgacctg 720
gttgagcaag cgagcgatca gcaccaggcg gaagagatga acgccgaaga tccgctgttt 780
attctctaca cctccggttc taccggtaag ccaaaaggtg tgctgcatac taccggcggt 840
tatctggtgt acgcggcgct gacctttaaa tatgtctttg attatcatcc gggtgatatc 900
tactggtgca ccgccgatgt gggctgggtg accggacaca gttacttgct gtacggcccg 960
ctggcctgcg gtgcgaccac gctgatgttt gaaggcgtac ccaactggcc gacgcctgcc 1020
cgtatggcgc aggtggtgga caagcatcag gtcaatattc tctataccgc acccacggcg 1080
atccgcgcgc tgatggcgga aggcgataaa gcgatcgaag gcaccgaccg ttcgtcgctg 1140
cgcattctcg gttccgtggg cgagccaatt aacccggaag cgtgggagtg gtactggaaa 1200
aaaatcggca acgagaaatg tccggtggtc gatacctggt ggcagaccga aaccggcggt 1260
ttcatgatca ccccgctgcc tggcgctacc gagctgaaag ccggttcggc aacacgtccg 1320
ttcttcggcg tgcaaccggc gctggtcgat aacgaaggta acccgctgga gggggccacc 1380
gaaggtagcc tggtaatcac cgactcctgg ccgggtcagg cgcgtacgct gtttggcgat 1440
cacgaacgtt ttgaacagac ctacttctcc accttcaaaa atatgtattt cagcggcgac 1500
ggcgcgcgtc gcgatgaaga tggctattac tggataaccg ggcgtgtgga cgacgtgctg 1560
aacgtctccg gtcaccgtct ggggacggca gagattgagt cggcgctggt ggcgcatccg 1620
aagattgccg aagccgccgt agtaggtatt ccgcacaata ttaaaggtca ggcgatctac 1680
gcctacgtca cgcttaatca cggggaggaa ccgtcaccag aactgtacgc agaagtccgc 1740
aactgggtgc gtaaagagat tggcccgctg gcgacgccag acgtgctgca ctggaccgac 1800
tccctgccta aaacccgctc cggcaaaatt atgcgccgta ttctgcgcaa aattgcggcg 1860
ggcgatacca gcaacctggg cgatacctcg acgcttgccg atcctggcgt agtcgagaag 1920
ctgcttgaag agaagcaggc tatcgcgatg ccatcgtaa 1959
<210> 4
<211> 1284
<212> DNA
<213> 大肠杆菌(E. coli)ATCC 27325
<400> 4
atggctgata caaaagcaaa actcaccctc aacggggata cagctgttga actggatgtg 60
ctgaaaggca cgctgggtca agatgttatt gatatccgta ctctcggttc aaaaggtgtg 120
ttcacctttg acccaggctt cacttcaacc gcatcctgcg aatctaaaat tacttttatt 180
gatggtgatg aaggtatttt gctgcaccgc ggtttcccga tcgatcagct ggcgaccgat 240
tctaactacc tggaagtttg ttacatcctg ctgaatggtg aaaaaccgac tcaggaacag 300
tatgacgaat ttaaaactac ggtgacccgt cataccatga tccacgagca gattacccgt 360
ctgttccatg ctttccgtcg cgactcgcat ccaatggcag tcatgtgtgg tattaccggc 420
gcgctggcgg cgttctatca cgactcgctg gatgttaaca atcctcgtca ccgtgaaatt 480
gccgcgttcc gcctgctgtc gaaaatgccg accatggccg cgatgtgtta caagtattcc 540
attggtcagc catttgttta cccgcgcaac gatctctcct acgccggtaa cttcctgaat 600
atgatgttct ccacgccgtg cgaaccgtat gaagttaatc cgattctgga acgtgctatg 660
gaccgtattc tgatcctgca cgctgaccat gaacagaacg cctctacctc caccgtgcgt 720
accgctggct cttcgggtgc gaacccgttt gcctgtatcg cagcaggtat tgcttcactg 780
tggggacctg cgcacggcgg tgctaacgaa gcggcgctga aaatgctgga agaaatcagc 840
tccgttaaac acattccgga atttgttcgt cgtgcgaaag acaaaaatga ttctttccgc 900
ctgatgggct tcggtcaccg cgtgtacaaa aattacgacc cgcgcgccac cgtaatgcgt 960
gaaacctgcc atgaagtgct gaaagagctg ggcacgaagg atgacctgct ggaagtggct 1020
atggagctgg aaaacatcgc gctgaacgac ccgtacttta tcgagaagaa actgtacccg 1080
aacgtcgatt tctactctgg tatcatcctg aaagcgatgg gtattccgtc ttccatgttc 1140
accgtcattt tcgcaatggc acgtaccgtt ggctggatcg cccactggag cgaaatgcac 1200
agtgacggta tgaagattgc ccgtccgcgt cagctgtata caggatatga aaaacgcgac 1260
tttaaaagcg atatcaagcg ttaa 1284
<210> 5
<211> 2652
<212> DNA
<213> 大肠杆菌(E. coli)ATCC 27325
<400> 5
atgaacgaac aatattccgc attgcgtagt aatgtcagta tgctcggcaa agtgctggga 60
gaaaccatca aggatgcgtt gggagaacac attcttgaac gcgtagaaac tatccgtaag 120
ttgtcgaaat cttcacgcgc tggcaatgat gctaaccgcc aggagttgct caccacctta 180
caaaatttgt cgaacgacga gctgctgccc gttgcgcgtg cgtttagtca gttcctgaac 240
ctggccaaca ccgccgagca ataccacagc atttcgccga aaggcgaagc tgccagcaac 300
ccggaagtga tcgcccgcac cctgcgtaaa ctgaaaaacc agccggaact gagcgaagac 360
accatcaaaa aagcagtgga atcgctgtcg ctggaactgg tcctcacggc tcacccaacc 420
gaaattaccc gtcgtacact gatccacaaa atggtggaag tgaacgcctg tttaaaacag 480
ctcgataaca aagatatcgc tgactacgaa cacaaccagc tgatgcgtcg cctgcgccag 540
ttgatcgccc agtcatggca taccgatgaa atccgtaagc tgcgtccaag cccggtagat 600
gaagccaaat ggggctttgc cgtagtggaa aacagcctgt ggcaaggcgt accaaattac 660
ctgcgcgaac tgaacgaaca actggaagag aacctcggct acaaactgcc cgtcgaattt 720
gttccggtcc gttttacttc gtggatgggc ggcgaccgcg acggcaaccc gaacgtcact 780
gccgatatca cccgccacgt cctgctactc agccgctgga aagccaccga tttgttcctg 840
aaagatattc aggtgctggt ttctgaactg tcgatggttg aagcgacccc tgaactgctg 900
gcgctggttg gcgaagaagg tgccgcagaa ccgtatcgct atctgatgaa aaacctgcgt 960
tctcgcctga tggcgacaca ggcatggctg gaagcgcgcc tgaaaggcga agaactgcca 1020
aaaccagaag gcctgctgac acaaaacgaa gaactgtggg aaccgctcta cgcttgctac 1080
cagtcacttc aggcgtgtgg catgggtatt atcgccaacg gcgatctgct cgacaccctg 1140
cgccgcgtga aatgtttcgg cgtaccgctg gtccgtattg atatccgtca ggagagcacg 1200
cgtcataccg aagcgctggg cgagctgacc cgctacctcg gtatcggcga ctacgaaagc 1260
tggtcagagg ccgacaaaca ggcgttcctg atccgcgaac tgaactccaa acgtccgctt 1320
ctgccgcgca actggcaacc aagcgccgaa acgcgcgaag tgctcgatac ctgccaggtg 1380
attgccgaag caccgcaagg ctccattgcc gcctacgtga tctcgatggc gaaaacgccg 1440
tccgacgtac tggctgtcca cctgctgctg aaagaagcgg gtatcgggtt tgcgatgccg 1500
gttgctccgc tgtttgaaac cctcgatgat ctgaacaacg ccaacgatgt catgacccag 1560
ctgctcaata ttgactggta tcgtggcctg attcagggca aacagatggt gatgattggc 1620
tattccgact cagcaaaaga tgcgggagtg atggcagctt cctgggcgca atatcaggca 1680
caggatgcat taatcaaaac ctgcgaaaaa gcgggtattg agctgacgtt gttccacggt 1740
cgcggcggtt ccattggtcg cggcggcgca cctgctcatg cggcgctgct gtcacaaccg 1800
ccaggaagcc tgaaaggcgg cctgcgcgta accgaacagg gcgagatgat ccgctttaaa 1860
tatggtctgc cagaaatcac cgtcagcagc ctgtcgcttt ataccggggc gattctggaa 1920
gccaacctgc tgccaccgcc ggagccgaaa gagagctggc gtcgcattat ggatgaactg 1980
tcagtcatct cctgcgatgt ctaccgcggc tacgtacgtg aaaacaaaga ttttgtgcct 2040
tacttccgct ccgctacgcc ggaacaagaa ctgggcaaac tgccgttggg ttcacgtccg 2100
gcgaaacgtc gcccaaccgg cggcgtcgag tcactacgcg ccattccgtg gatcttcgcc 2160
tggacgcaaa accgtctgat gctccccgcc tggctgggtg caggtacggc gctgcaaaaa 2220
gtggtcgaag acggcaaaca gagcgagctg gaggctatgt gccgcgattg gccattcttc 2280
tcgacgcgtc tcggcatgct ggagatggtc ttcgccaaag cagacctgtg gctggcggaa 2340
tactatgacc aacgcctggt agacaaagca ctgtggccgt taggtaaaga gttacgcaac 2400
ctgcaagaag aagacatcaa agtggtgctg gcgattgcca acgattccca tctgatggcc 2460
gatctgccgt ggattgcaga gtctattcag ctacggaata tttacaccga cccgctgaac 2520
gtattgcagg ccgagttgct gcaccgctcc cgccaggcag aaaaagaagg ccaggaaccg 2580
gatcctcgcg tcgaacaagc gttaatggtc actattgccg ggattgcggc aggtatgcgt 2640
aataccggct aa 2652
<210> 6
<211> 1203
<212> DNA
<213> 大肠杆菌(E. coli)ATCC 27325
<400> 6
atgtcgagta agttagtact ggttctgaac tgcggtagtt cttcactgaa atttgccatc 60
atcgatgcag taaatggtga agagtacctt tctggtttag ccgaatgttt ccacctgccc 120
gaagcacgta tcaaatggaa aatggacggc aataaacagg aagcggcttt aggtgcaggc 180
gccgctcaca gcgaagcgct caactttatc gttaatacta ttctggcaca aaaaccagaa 240
ctgtctgcgc agctgactgc tatcggtcac cgtatcgtac acggcggcga aaagtatacc 300
agctccgtag tgatcgatga gtctgttatt cagggtatca aagatgcagc ttcttttgca 360
ccgctgcaca acccggctca cctgatcggt atcgaagaag ctctgaaatc tttcccacag 420
ctgaaagaca aaaacgttgc tgtatttgac accgcgttcc accagactat gccggaagag 480
tcttacctct acgccctgcc ttacaacctg tacaaagagc acggcatccg tcgttacggc 540
gcgcacggca ccagccactt ctatgtaacc caggaagcgg caaaaatgct gaacaaaccg 600
gtagaagaac tgaacatcat cacctgccac ctgggcaacg gtggttccgt ttctgctatc 660
cgcaacggta aatgcgttga cacctctatg ggcctgaccc cgctggaagg tctggtcatg 720
ggtacccgtt ctggtgatat cgatccggcg atcatcttcc acctgcacga caccctgggc 780
atgagcgttg acgcaatcaa caaactgctg accaaagagt ctggcctgct gggtctgacc 840
gaagtgacca gcgactgccg ctatgttgaa gacaactacg cgacgaaaga agacgcgaag 900
cgcgcaatgg acgtttactg ccaccgcctg gcgaaataca tcggtgccta cactgcgctg 960
atggatggtc gtctggacgc tgttgtattc actggtggta tcggtgaaaa tgccgcaatg 1020
gttcgtgaac tgtctctggg caaactgggc gtgctgggct ttgaagttga tcatgaacgc 1080
aacctggctg cacgtttcgg caaatctggt ttcatcaaca aagaaggtac ccgtcctgcg 1140
gtggttatcc caaccaacga agaactggtt atcgcgcaag acgcgagccg cctgactgcc 1200
tga 1203
<210> 7
<211> 21
<212> DNA
<213> 人工序列
<400> 7
tgggaagaaa ccacgaaact c 21
<210> 8
<211> 77
<212> DNA
<213> 人工序列
<400> 8
aattgttatc cgctcacaat tccacacatt atacgagccg gatgattaat tgtcaatgtt 60
tcagcaggta ggcgaga 77
<210> 9
<211> 77
<212> DNA
<213> 人工序列
<400> 9
ctgggccttt cgttttatct gttgtttgtc ggtgaacgct ctcctgagta ggacaaataa 60
aacggtcgcc tggtacg 77
<210> 10
<211> 19
<212> DNA
<213> 人工序列
<400> 10
ttatccgccg acattgctg 19
<210> 11
<211> 85
<212> DNA
<213> 人工序列
<400> 11
tccggctcgt ataatgtgtg gaattgtgag cggataacaa tttcacacag gaaacagacc 60
atgacctctc cggttatcgg taccc 85
<210> 12
<211> 79
<212> DNA
<213> 人工序列
<400> 12
acaaacaaca gataaaacga aaggcccagt ctttcgactg agcctttcgt tttatttgtc 60
attcgttgtc acccgcggt 79
<210> 13
<211> 56
<212> DNA
<213> 人工序列
<400> 13
agtcctaggt ataatactag ttatcattcc ccacactacg ggttttagag ctagaa 56
<210> 14
<211> 56
<212> DNA
<213> 人工序列
<400> 14
ttctagctct aaaacccccc gtagtgtggg gaatgactag tattatacct aggact 56
<210> 15
<211> 25
<212> DNA
<213> 人工序列
<400> 15
aatagttgtt gccgcctgag taact 25
<210> 16
<211> 81
<212> DNA
<213> 人工序列
<400> 16
aattgttatc cgctcacaat tccacacatt atacgagccg gatgattaat tgtcaagcag 60
ccagtaatct tccatccctt t 81
<210> 17
<211> 85
<212> DNA
<213> 人工序列
<400> 17
aaagactggg cctttcgttt tatctgttgt ttgtcggtga acgctctcct gagtaggaca 60
aatatcggat tcgcaccgga agaga 85
<210> 18
<211> 22
<212> DNA
<213> 人工序列
<400> 18
tgtcccgtgc cagaagatga gg 22
<210> 19
<211> 81
<212> DNA
<213> 人工序列
<400> 19
tccggctcgt ataatgtgtg gaattgtgag cggataacaa tttcacacag gaaacagacc 60
gtgtcccgta ttattatgct g 81
<210> 20
<211> 84
<212> DNA
<213> 人工序列
<400> 20
caccgacaaa caacagataa aacgaaaggc ccagtctttc gactgagcct ttcgttttat 60
ttgttactgc tgctgtgcag actg 84
<210> 21
<211> 56
<212> DNA
<213> 人工序列
<400> 21
agtcctaggt ataatactag tagggattat gaacggcaat ggttttagag ctagaa 56
<210> 22
<211> 56
<212> DNA
<213> 人工序列
<400> 22
ttctagctct aaaaccattg ccgttcataa tccctactag tattatacct aggact 56
<210> 23
<211> 22
<212> DNA
<213> 人工序列
<400> 23
ggcgattgct actgctgatg ct 22
<210> 24
<211> 78
<212> DNA
<213> 人工序列
<400> 24
aattgttatc cgctcacaat tccacacatt atacgagccg gatgattaat tgtcaaccca 60
atactgggcg aagggaga 78
<210> 25
<211> 85
<212> DNA
<213> 人工序列
<400> 25
aaagactggg cctttcgttt tatctgttgt ttgtcggtga acgctctcct gagtaggaca 60
aatcgctgcc aaggactctg aggat 85
<210> 26
<211> 22
<212> DNA
<213> 人工序列
<400> 26
tagggcattg ggagggcgat tt 22
<210> 27
<211> 81
<212> DNA
<213> 人工序列
<400> 27
tccggctcgt ataatgtgtg gaattgtgag cggataacaa tttcacacag gaaacagacc 60
atgagccaaa ttcacaaaca c 81
<210> 28
<211> 84
<212> DNA
<213> 人工序列
<400> 28
caccgacaaa caacagataa aacgaaaggc ccagtctttc gactgagcct ttcgttttat 60
ttgttacgat ggcatcgcga tagc 84
<210> 29
<211> 56
<212> DNA
<213> 人工序列
<400> 29
agtcctaggt ataatactag tcattaccac ttatggcgaa cgttttagag ctagaa 56
<210> 30
<211> 56
<212> DNA
<213> 人工序列
<400> 30
ttctagctct aaaacgttcg ccataagtgg taatgactag tattatacct aggact 56
<210> 31
<211> 20
<212> DNA
<213> 人工序列
<400> 31
acccaacctt acgcaaccag 20
<210> 32
<211> 76
<212> DNA
<213> 人工序列
<400> 32
aattgttatc cgctcacaat tccacacatt atacgagccg gatgattaat tgtcaattgt 60
tcgataaccg cagcat 76
<210> 33
<211> 80
<212> DNA
<213> 人工序列
<400> 33
aaagactggg cctttcgttt tatctgttgt ttgtcggtga acgctctcct gagtaggaca 60
aatcgctggc gtgctttgaa 80
<210> 34
<211> 19
<212> DNA
<213> 人工序列
<400> 34
ggcgtaactc agcaggcag 19
<210> 35
<211> 84
<212> DNA
<213> 人工序列
<400> 35
tccggctcgt ataatgtgtg gaattgtgag cggataacaa tttcacacag gaaacagacc 60
atggctgata caaaagcaaa actc 84
<210> 36
<211> 88
<212> DNA
<213> 人工序列
<400> 36
caccgacaaa caacagataa aacgaaaggc ccagtctttc gactgagcct ttcgttttat 60
ttgttaacgc ttgatatcgc ttttaaag 88
<210> 37
<211> 56
<212> DNA
<213> 人工序列
<400> 37
agtcctaggt ataatactag tacactggct ggatgtgcaa cgttttagag ctagaa 56
<210> 38
<211> 56
<212> DNA
<213> 人工序列
<400> 38
ttctagctct aaaacgttgc acatccagcc agtgtactag tattatacct aggact 56
<210> 39
<211> 20
<212> DNA
<213> 人工序列
<400> 39
ttcatcggga cgagtggaga 20
<210> 40
<211> 76
<212> DNA
<213> 人工序列
<400> 40
aattgttatc cgctcacaat tccacacatt atacgagccg gatgattaat tgtcaaccat 60
agcatcgcca atctga 76
<210> 41
<211> 80
<212> DNA
<213> 人工序列
<400> 41
ctgggccttt cgttttatct gttgtttgtc ggtgaacgct ctcctgagta ggacaaatac 60
ccaaaggtga agataaagcc 80
<210> 42
<211> 24
<212> DNA
<213> 人工序列
<400> 42
cattccctct acagaactag ccct 24
<210> 43
<211> 82
<212> DNA
<213> 人工序列
<400> 43
tccggctcgt ataatgtgtg gaattgtgag cggataacaa tttcacacag gaaacagacc 60
atgaacgaac aatattccgc at 82
<210> 44
<211> 80
<212> DNA
<213> 人工序列
<400> 44
acaaacaaca gataaaacga aaggcccagt ctttcgactg agcctttcgt tttatttgtt 60
agccggtatt acgcatacct 80
<210> 45
<211> 56
<212> DNA
<213> 人工序列
<400> 45
agtcctaggt ataatactag taacacagca atacggtacg cgttttagag ctagaa 56
<210> 46
<211> 56
<212> DNA
<213> 人工序列
<400> 46
ttctagctct aaaacgcgta ccgtattgct gtgttactag tattatacct aggact 56
<210> 47
<211> 22
<212> DNA
<213> 人工序列
<400> 47
actggttctg aactgcggta gt 22
<210> 48
<211> 22
<212> DNA
<213> 人工序列
<400> 48
tgtaaggcag ggcgtagagg ta 22
<210> 49
<211> 21
<212> DNA
<213> 人工序列
<400> 49
aatgccgcaa tggttcgtga a 21
<210> 50
<211> 20
<212> DNA
<213> 人工序列
<400> 50
gccgtcgtgg tggaagagtt 20
<210> 51
<211> 56
<212> DNA
<213> 人工序列
<400> 51
agtcctaggt ataatactag tcttctatgt aacccaggaa ggttttagag ctagaa 56
<210> 52
<211> 56
<212> DNA
<213> 人工序列
<400> 52
ttctagctct aaaaccttcc tgggttacat agaagactag tattatacct aggact 56
Claims (8)
1.一株产L-茶氨酸的基因工程菌,其特征在于,是以大肠杆菌(Escherichia coli)W3110基因组上单拷贝RNA聚合酶基因T7RNAP、双拷贝γ-谷氨酰甲胺合成酶基因gmas、敲除木糖操纵子阻遏蛋白基因xylR、敲除琥珀酰CoA合成酶基因sucCD后获得菌株为出发菌种,在基因组上整合6-磷酸果糖解酮酶基因xfp、磷酸乙酰基转移酶基因pta、乙酰辅酶A合成酶基因acs、柠檬酸合酶基因gltA、磷酸烯醇丙酮酸羧化酶基因ppc,敲除乙酸激酶基因ackA获得;
所述RNA聚合酶基因T7RNAP,来源于T7噬菌体,核苷酸序列见CN 109370966B序列1;
所述γ-谷氨酰甲胺合成酶基因gmas,来源于Methylovorus mays,核苷酸序列见CN109370966B序列2;
所述6-磷酸果糖解酮酶基因xfp,核苷酸序列如序列表SEQ ID NO.1所示;
所述磷酸乙酰基转移酶基因pta,核苷酸序列如序列表SEQ ID NO.2所示;
所述乙酰辅酶A合成酶基因acs,核苷酸序列如序列表SEQ ID NO.3所示;
所述柠檬酸合酶基因gltA,核苷酸序列如序列表SEQ ID NO.4所示;
所述磷酸烯醇丙酮酸羧化酶基因ppc,核苷酸序列如序列表SEQ ID NO.5所示;
所述乙酸激酶基因ackA,核苷酸序列如序列表SEQ ID NO.6所示。
2.如权利要求1所述的基因工程菌,其特征在于,xfp、pta、acs、gltA、ppc基因均分别由trc启动子控制。
3.权利要求1-2任意一项所述的基因工程菌的构建方法,其特征在于,采用CRISPR/Cas9介导的基因编辑技术对大肠杆菌进行定向改造,在出发菌株基因组gapC位点单拷贝6-磷酸果糖解酮酶基因xfp,在yjiT位点单拷贝乙酰基转移酶基因pta,在yghE位点单拷贝乙酰辅酶A合成酶基因acs,在ylbE位点单拷贝磷酸乙酰基转移酶gltA,在yeeL位点单拷贝磷酸烯醇丙酮酸羧化酶ppc,敲除出发菌株基因组上的乙酸激酶基因ackA;上述构建顺序不分先后。
4.权利要求1或2所述的基因工程菌的应用,其特征在于,具体为在采用发酵法生产L-茶氨酸中的应用。
5.如权利要求4所述的应用,其特征在于,采用发酵法生产L-茶氨酸的方法如下:将种子液按照10-15%接种量接入发酵培养基,发酵过程中控制pH在6.7-7.2,温度维持在28-36℃,溶氧在10-30%之间;当培养基中的葡萄糖消耗完之后,流加葡萄糖溶液并维持发酵培养基中的葡萄糖浓度<1g/L;
发酵过程中采用OD联动的乙胺补加策略,当OD600nm达到8-12以上时开始添加乙胺,每0.8-1.2小时调节一次乙胺流加速率;乙胺流加速率(g·L-1·h-1)=0.5×OD600nm值/(发酵液体积(L)×发酵时间(h))。
6.如权利要求5所述的应用,其特征在于,发酵培养基组成为:葡萄糖10-40g/L,酵母粉2-8g/L,玉米浆2-20ml/L,柠檬酸0.2-2.0g/L,磷酸二氢钾0.5-3.2g/L,磷酸氢二钾0.5-2.4g/L,硫酸镁0.2-1.2g/L,其余为水,pH 7.0-7.2。
7.如权利要求5所述的应用,其特征在于,从发酵液中分离提取L-茶氨酸,方法如下:
(1)将L-茶氨酸发酵液加热升温至55-60℃维持20-30min后降温至35-40℃,过50-70nm陶瓷膜进行微滤除菌并收集滤出液,0.2-0.3Mpa压力下,当滤出液流速低于5mL/min时,补加0.5-1倍发酵液体积的水,直至截留液中L-茶氨酸浓度小于2g/L时,结束陶瓷膜微滤;
(2)将陶瓷膜滤液过阳离子树脂吸附L-茶氨酸,然后用质量分数为0.5%-1%的氨水进行洗脱收集;将洗脱液过阴离子树脂吸附色素,收集树脂流出液;
(3)将树脂流出液泵入脱色罐中,加入L-茶氨酸质量1%-3%的药用活性炭进行脱色处理,至料液透光率达到96%以上;将脱色液泵入蒸发器中进行减压浓缩至体积浓缩倍数为6-9倍;
(4)将浓缩液泵入结晶罐中,加入浓缩液体积30%-50%的乙醇,真空冷却结晶,离心分离收集湿晶体,烘干后得到L-茶氨酸成品。
8.如权利要求7所述的应用,其特征在于,所述阳离子树脂为001×7苯乙烯系强酸阳离子交换树脂;所述的阴离子树脂为D213丙烯酸系强碱阴离子交换树脂。
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111159099.6A CN113774075B (zh) | 2021-09-30 | 2021-09-30 | 一株大肠杆菌基因工程菌及其发酵生产l-茶氨酸的方法 |
US17/566,702 US11453898B1 (en) | 2021-09-30 | 2021-12-31 | Genetically engineered bacterium of Escherichia coli and method for fermentation production of L-theanine thereof |
US17/889,397 US12065682B2 (en) | 2021-09-30 | 2022-08-17 | Method for producing L-theanine via fermentation by a genetically engineered bacterium and the application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111159099.6A CN113774075B (zh) | 2021-09-30 | 2021-09-30 | 一株大肠杆菌基因工程菌及其发酵生产l-茶氨酸的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113774075A CN113774075A (zh) | 2021-12-10 |
CN113774075B true CN113774075B (zh) | 2023-08-08 |
Family
ID=78854756
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111159099.6A Active CN113774075B (zh) | 2021-09-30 | 2021-09-30 | 一株大肠杆菌基因工程菌及其发酵生产l-茶氨酸的方法 |
Country Status (2)
Country | Link |
---|---|
US (2) | US11453898B1 (zh) |
CN (1) | CN113774075B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114410504B (zh) * | 2021-12-15 | 2025-01-24 | 新疆阜丰生物科技有限公司 | 一种发酵提取茶氨酸的方法 |
CN114480522A (zh) * | 2021-12-16 | 2022-05-13 | 精晶药业股份有限公司 | 一种微生物发酵制备l-茶氨酸的方法 |
CN114874959B (zh) * | 2022-04-27 | 2024-04-16 | 天津科技大学 | 一种利用葡萄糖从头发酵生产l-茶氨酸的基因工程菌、方法及应用 |
CN116004490A (zh) * | 2022-07-12 | 2023-04-25 | 华东理工大学 | 一种生物合成右旋-双环吉玛烯的重组大肠杆菌、构建方法及应用 |
CN117821356B (zh) * | 2024-03-05 | 2024-06-04 | 天津科技大学 | 一种提高l-茶氨酸从头发酵产量和转化率的基因工程菌株、方法和应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107815444A (zh) * | 2017-10-31 | 2018-03-20 | 中国科学院天津工业生物技术研究所 | 一种用于atp再生的底盘系统与应用 |
CN109370966A (zh) * | 2018-10-18 | 2019-02-22 | 天津科技大学 | 一种用于l-茶氨酸生产的基因工程菌及其发酵方法 |
CN109777763A (zh) * | 2019-03-29 | 2019-05-21 | 天津科技大学 | 一株用于l-茶氨酸生产的基因工程菌及其构建与应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102719367B (zh) | 2012-07-10 | 2013-06-12 | 湖南农业大学 | 一种微生物产γ-谷氨基甲酰胺合成酶催化合成L-茶氨酸的方法 |
CN103409475B (zh) | 2013-07-18 | 2017-03-08 | 江南大学 | 一种酶法合成l‑茶氨酸的方法 |
CN104087535B (zh) | 2014-07-10 | 2017-01-11 | 南通励成生物工程有限公司 | 生物法制备茶氨酸的方法 |
CN105061249B (zh) | 2015-09-11 | 2017-01-04 | 长沙市博泰生物科技有限公司 | 一种茶氨酸的提取方法 |
CN106893748B (zh) | 2015-12-21 | 2020-11-17 | 中国科学院天津工业生物技术研究所 | 一种l-茶氨酸的合成方法 |
US11939615B2 (en) * | 2017-06-15 | 2024-03-26 | Anhui Gsh Bio-Tech Co., Ltd. | Production method of enzymatic reaction using adenosine instead of ATP |
CN109851520A (zh) | 2019-02-24 | 2019-06-07 | 内蒙古拜克生物有限公司 | 一种l-茶氨酸的分离纯化方法 |
CN114874959B (zh) * | 2022-04-27 | 2024-04-16 | 天津科技大学 | 一种利用葡萄糖从头发酵生产l-茶氨酸的基因工程菌、方法及应用 |
-
2021
- 2021-09-30 CN CN202111159099.6A patent/CN113774075B/zh active Active
- 2021-12-31 US US17/566,702 patent/US11453898B1/en active Active
-
2022
- 2022-08-17 US US17/889,397 patent/US12065682B2/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107815444A (zh) * | 2017-10-31 | 2018-03-20 | 中国科学院天津工业生物技术研究所 | 一种用于atp再生的底盘系统与应用 |
CN109370966A (zh) * | 2018-10-18 | 2019-02-22 | 天津科技大学 | 一种用于l-茶氨酸生产的基因工程菌及其发酵方法 |
CN109777763A (zh) * | 2019-03-29 | 2019-05-21 | 天津科技大学 | 一株用于l-茶氨酸生产的基因工程菌及其构建与应用 |
Non-Patent Citations (1)
Title |
---|
Xiaoguang Fan等.Pathway engineering of Escherichia coli for one-step fermentative production of L-theanine from sugars and ethylamine.《Metabolic Engineering Communications》.2020,第1-10页. * |
Also Published As
Publication number | Publication date |
---|---|
CN113774075A (zh) | 2021-12-10 |
US12065682B2 (en) | 2024-08-20 |
US11453898B1 (en) | 2022-09-27 |
US20230109256A1 (en) | 2023-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113774075B (zh) | 一株大肠杆菌基因工程菌及其发酵生产l-茶氨酸的方法 | |
US11512333B2 (en) | Method for producing tetrahydropyrimidine by fermenting recombinant Corynebacterium glutamicum | |
JP5254353B2 (ja) | 2−デオキシ−シロ−イノソース(doi)生産細菌及びこれを用いた2−デオキシ−シロ−イノソース(doi)生産方法 | |
CN106754603A (zh) | 利用木糖诱导产生四氢嘧啶的基因工程菌及其应用 | |
CN109777763B (zh) | 一株用于l-茶氨酸生产的基因工程菌及其构建与应用 | |
CN114874964B (zh) | 一种高产2′-岩藻糖基乳糖的重组大肠杆菌的构建方法及应用 | |
CN112813085A (zh) | 焦磷酸酶基因的用途 | |
CN110373370B (zh) | 一种耦合atp再生系统的催化体系及其在生产谷胱甘肽过程中的应用 | |
KR20240017394A (ko) | L-시트룰린 생산능이 향상된 코리네박테리움 글루타미쿰 변이주 및 이를 이용한 l-시트룰린의 생산 방법 | |
CN115028694B (zh) | 与l-谷氨酸产量相关的蛋白及其相关生物材料和应用 | |
CN106701649B (zh) | 生产l-谷氨酰胺的菌株和生产l-谷氨酰胺的方法 | |
CN117586937B (zh) | 一种提高乳酰-n-四糖产量的重组大肠杆菌构建及应用 | |
CN101870961A (zh) | 一种从木糖母液得到木糖醇与d-半乳糖醇的方法 | |
JP7537014B2 (ja) | L-シトルリン生産能が向上したコリネバクテリウムグルタミクム変異株およびこれを用いたl-シトルリンの生産方法 | |
CN102199644B (zh) | 胞苷三磷酸的基因工程制备方法 | |
CN116063417A (zh) | Bbd29_14255基因突变体及其在制备l-谷氨酸中的应用 | |
JP7668374B2 (ja) | 副産物の生成が低減した2,3-ブタンジオール生産用の組換え微生物、及びこれを用いる2,3-ブタンジオールの生産方法 | |
CN112779199B (zh) | 一种表达亚磷酸盐脱氢酶的重组谷氨酸棒杆菌及其应用 | |
CN114989996B (zh) | 一种产对羟基苯甲酸甲酯的基因工程菌及其应用 | |
CN118109383B (zh) | 一种生产依克多因的重组菌及其构建方法和应用 | |
CN118525095A (zh) | L-组氨酸生产能力得到提高的埃希菌属变异株及利用其的l-组氨酸的生产方法 | |
CN113667627A (zh) | 一种提高l-谷氨酸生产效率的谷氨酸棒杆菌的构建及应用 | |
CN120210085A (zh) | 一种合成岩藻糖基乳糖的营养缺陷型基因工程菌及其制备方法和应用 | |
CN117535335A (zh) | Bbd29_12340基因启动子突变体及其在发酵生产l-谷氨酸中的应用 | |
KR20240013960A (ko) | L-아르기닌 또는 l-시트룰린 생산능이 향상된 코리네박테리움 속 미생물 및 이를 이용한 l-아르기닌 또는 l-시트룰린의 생산 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |